Mumbai, Feb. 10 -- Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer(R) by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for the ANDA, Lupin Pharmaceuticals, Inc. (Lupin) will market the product in the U.S.

Published by HT Digital Content Services with permission from Capital Market....